The Parallax View

Home
Archive
About
NewTopDiscussion
Use these to help make $XBI a better place
The Parallax View
8
1
8,500 words on $TRIL $ALXO $IMAB $STTK $OSE $GILD
The Parallax View
2
Targeted protein degradation and a new era of proteome therapy
The Parallax View
3
Will eganelisib take $INFI to infinity and beyond?
The Parallax View
3
3
Our world in charts
The Parallax View
3
Using the microbiome to treat atopic dermatitis
The Parallax View
3
Looking at portfolio changes for RA, Perceptive, Baker, OrbiMed, BVF, EcoR1, Redmile, Opaleye, Ghost Tree
The Parallax View
3
Drugging the undruggable, not redrugging the druggable
The Parallax View
4
2,700 words
The Parallax View
2
An exciting approach to auto-immune conditions published in Science shows the broad potential of future mRNA therapies
The Parallax View
2
Recapping a year of buyout rumors
The Parallax View
1
2,000 words
The Parallax View
1
© 2022 Substack Inc
Privacy ∙ Terms ∙ Collection notice
Publish on Substack Get the app
Substack is the home for great writing